# DESCRIPTION

## TECHNICAL FIELD

- introduce lung adenocarcinoma prognosis prediction

## BACKGROUND ART

- describe lung cancer mortality rate
- discuss limitations of postoperative adjuvant chemotherapy
- summarize reports on postoperative adjuvant chemotherapy efficacy
- introduce biomarkers for prognosis prediction
- describe immunobiochemical identification method
- discuss limitations of pathological proteomics approach
- introduce sample analysis method and program
- discuss myosin IIA and vimentin functions
- summarize correlation between vimentin and epithelial-interstitial transition

## DISCLOSURE OF THE INVENTION

- motivate need for lung adenocarcinoma prognosis prediction
- introduce method and test kit for prognosis prediction
- summarize invention embodiments

## BEST MODE FOR CARRYING OUT THE INVENTION

- introduce method for predicting postoperative prognosis of lung adenocarcinoma patient
- describe steps of method: determining expression levels of myosin IIA and/or vimentin
- specify biological sample used: tissue, blood, or urine collected from patient
- describe determination of expression levels of myosin IIA and/or vimentin
- specify use of monoclonal antibody against analyte protein
- describe production of monoclonal antibody
- specify use of test kit for predicting prognosis
- describe composition of test kit: antibody that specifically binds to myosin IIA and/or vimentin
- specify use of immunohistochemical staining to determine expression level
- describe calculation of percentage of cells expressing analyte protein
- specify prediction of poor prognosis based on expression level
- describe advantages of method: excellent sensitivity and specificity
- describe potential applications of method: administration of anti-cancer agent, medical economy

### Example 1

- introduce example: searching for proteins that allow prediction of prognosis of early lung adenocarcinoma patient
- describe sample preparation: surgically excised tissue specimens
- specify protein extraction and digestion method
- describe determination of total protein concentration
- specify SDS-PAGE method
- describe trypsin digestion in gel
- specify LC-MS/MS method
- describe data analysis: i-OPAL program
- specify database search: Swiss-Prot human subset database and RefSeq protein sequence database
- describe results: detection of myosin IIA and vimentin as biomarker candidates
- specify significance of results: prediction of poor prognosis

### Example 2

- identify prognosis factors
- describe sample selection
- outline immunohistochemical staining
- determine staining results
- perform statistical analysis
- present results
- analyze survival curves
- conclude prognosis factors

## INDUSTRIAL APPLICABILITY

- claim industrial applicability

